Kathy Wilkinson on the Nurse's Role in Clinical Trials

Video
Conferences|ONS Annual Congress

Kathy Wilkinson, RN, BSN, OCN, Manager, Cancer Research, Billings Clinic Cancer Center, discusses the role that nurse's play in clinical trials.

Kathy Wilkinson, RN, BSN, OCN, Manager, Cancer Research, Billings Clinic Cancer Center, discusses the role that nurses play in clinical trials.

Wilkinson says a nurse’s relationship with a patient puts them in a prime position to talk about clinical trials. Nurses can educate patients about clinical trials and explain concepts to patients in terms that they can understand. Wilkinson says patients trust nurses to give them accurate information about what the trial is going to entail, including potential side effects.

<<<

View more from the 40th Annual ONS Congress

Recent Videos
Related Content
doctor in white coat holding hand out with the word "immunotherapy" floating above

Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers

Russ Conroy
November 12th 2024
Article

Adding E-602 to cemiplimab demonstrated anti-tumor effects in patients PD-L1–resistant solid cancers.

The Vitals

Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

Lindsay Fischer
June 15th 2023
Podcast

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

gynecologic cancer

Novel ADC Shows Promise in Platinum-Resistant Ovarian Cancer

Ryan Scott
November 5th 2024
Article

The novel drug SHR-A1921 was safe and efficacious in patients with platinum-resistant ovarian cancer, according to phase 1 data.

The Vitals

Seth Eisenberg Discusses New Methods of Reducing Hazardous Drug–Contaminated Toilet Aerosols in Hospital Setting

Lindsay Fischer
June 1st 2023
Podcast

Seth Eisenberg, ASN, RN, OCN, BMTCN, emphasizes the importance of reducing nurse exposure to hazardous drugs—and ongoing research efforts to improve nursing safety.

cells

NT-I7 Enhances CAR T-Cell Efficacy in DLBCL

Jax DiEugenio
October 11th 2024
Article

NT-17, a long-acting IL-7 agent, enhances CAR T-cell factors associated with efficacy in patients with relapsed/refractory DLBCL when administered 21 days post-CAR T infusion.

gastric system with stethoscope around it

Non-Operative Management of Rectal Cancer Does Not Worsen Distant RFS

Ariana Pelosci
September 25th 2024
Article

Distant relapse-free survival was maintained with non-operative management of pMMR locally advanced rectal cancer.

© 2024 MJH Life Sciences

All rights reserved.